Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.389, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Resource use varies according to race in OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 441, 2003-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Meloxicam cost saving over piroxicam and diclofenac in OA
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Meloxicam cost saving over piroxicam and diclofenac in OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 410, 2003-01 ,pp. :